Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK.
Saved in:
| Title: | Pirfenidone Is an Agonistic Ligand for PPARα and Improves NASH by Activation of SIRT1/LKB1/pAMPK. |
|---|---|
| Authors: | Sandoval-Rodriguez A; Department of Molecular Biology and Genomics Institute for Molecular Biology in Medicine and Gene Therapy Health Sciences University Center University of Guadalajara Guadalajara México., Monroy-Ramirez HC; Department of Molecular Biology and Genomics Institute for Molecular Biology in Medicine and Gene Therapy Health Sciences University Center University of Guadalajara Guadalajara México., Meza-Rios A; Tecnologico de Monterrey Campus Guadalajara Zapopan México., Garcia-Bañuelos J; Department of Molecular Biology and Genomics Institute for Molecular Biology in Medicine and Gene Therapy Health Sciences University Center University of Guadalajara Guadalajara México., Vera-Cruz J; Department of Molecular Biology and Genomics Institute for Molecular Biology in Medicine and Gene Therapy Health Sciences University Center University of Guadalajara Guadalajara México., Gutiérrez-Cuevas J; Department of Molecular Biology and Genomics Institute for Molecular Biology in Medicine and Gene Therapy Health Sciences University Center University of Guadalajara Guadalajara México., Silva-Gomez J; Department of Molecular Biology and Genomics Institute for Molecular Biology in Medicine and Gene Therapy Health Sciences University Center University of Guadalajara Guadalajara México., Staels B; Institut Pasteur de Lille Universite Lille Inserm, CHU Lille U1011-EGID Lille France., Dominguez-Rosales J; Chronic-Degenerative Diseases Institute Health Sciences University Center University of Guadalajara Guadalajara México., Galicia-Moreno M; Department of Molecular Biology and Genomics Institute for Molecular Biology in Medicine and Gene Therapy Health Sciences University Center University of Guadalajara Guadalajara México., Vazquez-Del Mercado M; IIRSME CUCS University of Guadalajara Guadalajara México., Navarro-Partida J; Tecnologico de Monterrey Campus Guadalajara Zapopan México., Santos-Garcia A; Tecnologico de Monterrey Campus Guadalajara Zapopan México., Armendariz-Borunda J; Department of Molecular Biology and Genomics Institute for Molecular Biology in Medicine and Gene Therapy Health Sciences University Center University of Guadalajara Guadalajara México.; Tecnologico de Monterrey Campus Guadalajara Zapopan México. |
| Source: | Hepatology communications [Hepatol Commun] 2020 Jan 16; Vol. 4 (3), pp. 434-449. Date of Electronic Publication: 2020 Jan 16 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
